Biolife Sciences (Biolife Sciences) ROCE % : 0.00% (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biolife Sciences's annualized ROCE % for the quarter that ended in May. 2008 was 0.00%.

Biolife Sciences ROCE % Historical Data

The historical data trend for Biolife Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences ROCE % Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

ROCE %

-30.43

-66.08

1.45

9.58

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
ROCE %	Get a 7-Day Free Trial										24.58	2.40	-91.56	-382.91	-

Biolife Sciences ROCE % Calculation

Biolife Sciences's annualized ROCE % for the fiscal year that ended in Nov. 2007 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Nov. 2007 )		(A: Nov. 2006 )		(A: Nov. 2007 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Nov. 2007 )		(A: Nov. 2006 )		(A: Nov. 2007 )
	=	0.039	/	( ( (3.474 - 2.926)	+	(3.762 - 3.496) )	/ 2 )
	=	0.039	/	( (0.548	+	0.266)	/ 2 )
	=	0.039	/	0.407
	=	9.58 %

Biolife Sciences's ROCE % of for the quarter that ended in May. 2008 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: May. 2008 )		(Q: Feb. 2008 )		(Q: May. 2008 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: May. 2008 )		(Q: Feb. 2008 )		(Q: May. 2008 )
	=	0.336	/	( ( (3.174 - 3.206)	+	(3.041 - 3.038) )	/ 2 )
	=	0.336	/	( ( -0.032	+	0.0030000000000001 )	/ 2 )
	=	0.336	/	-0.0145
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (May. 2008) EBIT data.

Biolife Sciences (OTCPK:BLFE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biolife Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020